Niebel, M. , Singer, J. B., Nickbakhsh, S. , Gifford, R. J. and Thomson, E. C. (2017) Hepatitis C and the absence of genomic data in low-income countries: a barrier on the road to elimination? Lancet Gastroenterology and Hepatology, 2(10), pp. 700-701. (doi: 10.1016/S2468-1253(17)30257-1) (PMID:28895545)
|
Text
147505.pdf - Accepted Version Available under License Creative Commons Attribution Non-commercial No Derivatives. 713kB |
Abstract
Following the development of highly effective direct acting antiviral (DAA) compounds for the treatment of the hepatitis C virus (HCV), WHO has set out plans for disease eradication by 2030. Many barriers must be surmounted before this can be achieved, including buy-in from governments and policy makers, reduced drug costs, and improved infrastructure for the pathway from diagnosis to treatment. A comprehensive set of guidelines was produced by WHO in 2014, updated in 2016, and they are due to be revised later this year.
| Item Type: | Articles (Letter) |
|---|---|
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | Gifford, Dr Robert and Thomson, Professor Emma and Nickbakhsh, Dr Sema and Niebel, Dr Marc and Singer, Dr Josh |
| Authors: | Niebel, M., Singer, J. B., Nickbakhsh, S., Gifford, R. J., and Thomson, E. C. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Infection & Immunity College of Medical Veterinary and Life Sciences > School of Infection & Immunity > Centre for Virus Research |
| Journal Name: | Lancet Gastroenterology and Hepatology |
| Publisher: | Elsevier |
| ISSN: | 2468-1253 |
| ISSN (Online): | 2468-1253 |
| Published Online: | 06 September 2017 |
| Copyright Holders: | Copyright © 2017 Elsevier |
| First Published: | First published in Lancet Gastroenterology and Hepatology 2(10):700-701 |
| Publisher Policy: | Reproduced in accordance with the copyright policy of the publisher. |
University Staff: Request a correction | Enlighten Editors: Update this record
Altmetric
Altmetric